Daño coronario secundario a enfermedad de Kawasaki

Schroh, Ana M.; Melonari, Pablo; Laghezza, Lidia B.; Domínguez, Pablo; Pierini, Florencia; Retamales, Eliana P.; Rodríguez, María Fernández; González, Gabriela E.

doi:10.7775/rac.es.v83.i1.5351

Cited by 4 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…49 En otro estudio, se asoció a la presencia de otras alteraciones cardíacas, PCR > 100 mg/dl, leucocitosis > 20 000/mm 3 y VSG > 100 mm/1. a hora.…”

Section: Factores Predictores De Enfermedad Coronariaunclassified

“…49,[62][63][64] La probabilidad de regresión del aneurisma se asocia al tamaño inicial, 63,65 edad < 1 año al momento del diagnóstico, morfología fusiforme y localización distal. 62 En los pacientes con aneurismas coronarios p e r s i s t e n t e s , l a e s t e n o s i s s e c u n d a r i a a proliferación miointimal suele ser progresiva.…”

Section: Seguimiento Y Controlunclassified

“…62 En los pacientes con aneurismas coronarios p e r s i s t e n t e s , l a e s t e n o s i s s e c u n d a r i a a proliferación miointimal suele ser progresiva. 49,64 Los aneurismas gigantes presentan peor pronóstico por el riesgo de trombosis. [64][65][66] El IAM es la principal causa de mortalidad en estos pacientes y requieren seguimiento con test de estrés miocárdico, además de evaluar individualmente la necesidad de realizar angiografía coronaria y tratamiento por cateterismo o cirugía.…”

Section: Seguimiento Y Controlunclassified

See 2 more Smart Citations

Enfermedad de Kawasaki: Consenso interdisciplinario e intersociedades

2016

Arch Argent Pediat

View full text Add to dashboard Cite

“…49 En otro estudio, se asoció a la presencia de otras alteraciones cardíacas, PCR > 100 mg/dl, leucocitosis > 20 000/mm 3 y VSG > 100 mm/1. a hora.…”

Section: Factores Predictores De Enfermedad Coronariaunclassified

Section: Seguimiento Y Controlunclassified

See 1 more Smart Citation

Enfermedad de Kawasaki: Consenso interdisciplinario e intersociedades

2016

Arch Argent Pediat

View full text Add to dashboard Cite

“…[9][10][11] In Argentina, the studies by Schroh and Melonari reported coronary involvement in 16% of cases and the same risk factors mentioned above. 12,13 There are few publications in Argentina on KD. Therefore, our objective was to describe the clinical characteristics, coronary involvement, and course of patients with KD seen at a community teaching hospital.…”

Section: Introductionmentioning

confidence: 99%

Clinical characteristics and course of patients with Kawasaki disease at a general hospital

et al. 2022

View full text Add to dashboard Cite

Kawasaki disease (KD) is considered the leading cause of acquired heart disease in children younger than 5 years. Our objective was to know the clinical characteristics, coronary involvement, and course of patients seen at our facility.A case series from 2001 to 2018 was reviewed. Sixty-three patients were included; their median age was 2.6 years; 58% were males. The median duration of fever at the time of diagnosis was 5.5 days.The incomplete form was observed in 33% and coronary involvement, in 20%. Among patients with coronary involvement, 60% had incomplete KD versus 28% among those without coronary involvement (p: 0.06). No differences were observed between groups in laboratory data based on coronary involvement. To conclude, 33% had incomplete KD and 20%, coronary involvement. There was a trend to a higher risk for coronary artery damage in the incomplete form of KD.

show abstract

“…El ecocardiograma doppler color (EDC) es el método diagnóstico de elección para la detección de CC, afectación cardíaca concomitante (ACC) y de arterias periféricas 12,17,18 .…”

unclassified

Características clínico-epidemiológicas y predictores de complicaciones coronarias en niños de Argentina con enfermedad de Kawasaki

Melonari¹,

Abate²,

López³

et al. 2019

Rev. chil. infectol.

View full text Add to dashboard Cite

Clinical-epidemiological characteristics and predictors of coronary complications in children of Argentina with Kawasaki disease Background: Kawasaki disease (EK) is an acute systemic vasculitis with a risk of developing coronary aneurysms. Aim: To describe the clinical and epidemiological characteristics of children with EK in Argentina and to analyse the risk factors for the development of coronary's complications (CC). Methods: Multicenter, retrospective, cross-sectional, observational and analytical study. It included patients younger than 18 years of age diagnosed with EK in hospitals in Argentina, between January the 1 st , 2010 and December the 31 th , 2013. Results: N = 193 subjects. Age: medium: 29 months. Total incidence 5 cases / 10,000 hospital discharges. CC was observed in 15.5% of patients. Increased risk factors for CC: Elevated number of days with fever at the time of treatment placement (p = 0.0033); Increased of: heart frequency (p = 0.0021), erythrosedimentation (ESR) (p = 0.005), C-reactive protein (CRP) (p < 0.0001), leukocytes (p = 0.0006), neutrophils (p = 0.0021); Decreased of hematocrit (p = 0.0007) and hemoglobin (p < 0.0001).Association with CC: non-coronary cardiological alterations (OR = 10,818); PCR greater than 68 mg /L (OR = 11,596); leukocytes greater than 20,000 / mm 3 (OR = 4.316); and ESR greater than 64 mm / 1 hour (OR = 4.267). Conclusion: The most frequent form of presentation was complete EK, the risk of CC was higher in males, younger than 5 years old, the risk factors (clinical and laboratory) were similar to those described in the literature.

show abstract

Daño coronario secundario a enfermedad de Kawasaki

Cited by 4 publications

References 0 publications

Enfermedad de Kawasaki: Consenso interdisciplinario e intersociedades

Enfermedad de Kawasaki: Consenso interdisciplinario e intersociedades

Clinical characteristics and course of patients with Kawasaki disease at a general hospital

Características clínico-epidemiológicas y predictores de complicaciones coronarias en niños de Argentina con enfermedad de Kawasaki

Contact Info

Product

Resources

About